Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
104<br />
Klinische Forschung<br />
Liste der bewilligten Forschungsprojekte 2011<br />
Totalbetrag der bewilligten Mittel: CHF 4 555 000.–<br />
Bodis Stephan | KFS 02779-02-2011 | CHF 195 500.–<br />
Institut für Radio-Onkologie, Kantonsspital Aarau, Aarau<br />
Pilot study to assess the feasibility and toxicity of preoperative external beam radiotherapy<br />
for glioblastoma multiforme<br />
Boulay JeanLouis | KLS 02765-02-2011 | CHF 196 500.–<br />
Departement Biomedizin, Universitätsspital Basel, Basel<br />
Molecular mechanisms of glioma cell invasion<br />
Carbone Giuseppina | KFS 02869-08-2011 | CHF 136 200.–<br />
Laboratorio di oncologia sperimentale, Istituto oncologico della Svizzera italiana (IOSI), Bellinzona<br />
Identification and clinical relevance of microRNA networks regulated by ETS transcription factors in<br />
prostate cancer<br />
de Leval Laurence | KFS 02860-08-2011 | CHF 302 800.–<br />
Institut universitaire de pathologie (IUP), Centre hospitalier universitaire vaudois et Université de Lausanne<br />
(CHUV-UNIL), Lausanne<br />
Characterization of molecular biomarkers relevant to the biology, diagnosis and prognosis of peripheral<br />
T-cell lymphomas<br />
Derré Laurent | KLS 02744-02-2011 | CHF 191 400.–<br />
Unité de recherche en urologie, Centre hospitalier universitaire vaudois (CHUV), Lausanne<br />
Role of the inhibitory receptor BTLA in antigen presenting cells from melanoma and bladder cancer patients:<br />
importance of a novel dendritic cell subset<br />
Dummer Reinhard | KFS 02781-02-2011 | CHF 197 800.–<br />
Dermatologische Klinik, UniversitätsSpital Zürich, Zürich<br />
Functional genomics of cutaneous lymphoma<br />
Eychmüller Steffen | KFS 02848-08-2011 | CHF 140 000.–<br />
Palliative Care, Inselspital, Universitätsspital Bern, Bern<br />
Diagnosing dying: development of a tool for identifying the last days of life (LDoL)<br />
Ghadjar Pirus | KFS 02777-02-2011 | CHF 274 900.–<br />
Universitätsklinik für Radio-Onkologie, Inselspital, Universitätsspital Bern, Bern<br />
Dose-intensified salvage RT in biochemically relapsed prostate cancer without macroscopic disease:<br />
a randomized phase III trial (SAKK 09 / 10)<br />
Joerger Markus | KFS 02838-08-2011 | CHF 40 500.–<br />
Fachbereich Onkologie / Hämatologie, Kantonsspital St. Gallen, St. Gallen<br />
Clinical activity of tamoxifen in postmenopausal patients with locally advanced or metastatic ER-positive<br />
breast cancer by endoxifen concentrations and pharmacogenetics<br />
Kalberer Christian | KFS 02872-08-2011 | CHF 188 800.–<br />
Diagnostische Hämatologie, Universitätsspital Basel, Basel<br />
In vitro expansion of human natural killer cells under good manufacturing practice conditions<br />
for immunotherapy of haematopoietic malignancies<br />
Marra Giancarlo | KFS 02739-02-2011 | CHF 329 100.–<br />
Institut für molekulare Krebsforschung, Universität Zürich, Zürich<br />
The epigenome of colorectal transformation: from early tumours to liver metastases<br />
Pless Miklos | KLS 02745-02-2011 | CHF 145 800.–<br />
Medizinische Onkologie, Kantonsspital Winterthur, Winterthur<br />
Preoperative chemoradiotherapy vs. chemotherapy alone in non-small cell lung cancer patients with<br />
mediastinal lymph node metastases (stage IIIA, N2): a randomized prospective phase III trial (protocol<br />
SAKK 16 / 00)
Change language